Chimerix Inc... Show more
a developer of novel oral antiviral therapeutics
Industry Biotechnology
A.I.dvisor indicates that over the last year, CMRX has been loosely correlated with NAMS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CMRX jumps, then NAMS could also see price increases.
Ticker / NAME | Correlation To CMRX | 1D Price Change % | ||
---|---|---|---|---|
CMRX | 100% | N/A | ||
NAMS - CMRX | 49% Loosely correlated | +1.76% | ||
QURE - CMRX | 49% Loosely correlated | -2.97% | ||
CRDF - CMRX | 45% Loosely correlated | +2.90% | ||
AUPH - CMRX | 37% Loosely correlated | -2.09% | ||
DNA - CMRX | 30% Poorly correlated | +9.28% | ||
More |